Vergent is a biotechnology company focused on “lighting up” cancer to help surgeons quickly locate and completely remove tumors during resection surgery.

Vergent Bioscience

Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery

In the Know: Healthcare News for November 25, 2024

Vergent Bioscience Completes Enrollment in Phase 2 VISUALIZE Trial Evaluating Potential of Abenacianine for Injection (VGT-309) to Improve Tumor Visualization During Cancer Surgery